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Striking differences exist in outcomes for cancer between developed countries with comparable
healthcare systems. We compare the healthcare systems of 3 countries (Denmark, Norway, Sweden), 3
UK jurisdictions (England, Wales and Northern Ireland), 3 Canadian provinces (British Columbia, Man-
itoba, Ontario) and 2 Australian states (New South Wales, Victoria) using a framework which assesses the
possible contribution of primary care systems to a range of health outcomes, drawing on key charac-
teristics influencing population health.
For many of the characteristics we investigated there are no significant differences between those
countries with poorer cancer outcomes (England and Denmark) and the rest. In particular, regulation,
financing, the existence of patient lists, the GP gatekeeping role, direct access to secondary care, the
degree of comprehensiveness of primary care services, the level of cost sharing and the type of primary
care providers within healthcare systems were not specifically and consistently associated with differ-
ences between countries. Factors that could have an influence on patient and professional behaviour, and
consequently contribute to delays in cancer diagnosis and poorer cancer outcomes in some countries,
include centralisation of services, free movement of patients between primary care providers, access to
secondary care, and the existence of patient list systems.
It was not possible to establish a causal correlation between healthcare system characteristics and
cancer outcomes. Further studies should explore in greater depth the associations between single health
system factors and cancer outcomes, recognising that in complex systems where context is all-important,
it will be difficult to establish causal relationships. Better understanding of the interaction between
healthcare system variables and patient and professional behaviour may generate new hypotheses for
further research.
© 2014 The Authors. Published by Elsevier Ltd. This is an open access article under the CC BY-NC-ND
license (http://creativecommons.org/licenses/by-nc-nd/3.0/).1. Introduction
Striking differences in outcomes for cancer between developed
countries with comparable healthcare systems have been evident
since the first Eurocare study in 1995 (Berrino et al., 1995). Detailed
analyses of more recent Eurocare studies have allowed estimates of
avoidable premature mortality in Britain compared to the rest of
Europe (Abdel-Rahman et al., 2009), and have informed an English
policy objective of saving 5000 lives annually by 2014 (Department
of Health, 2011). Underpinning efforts to achieve this objective hasn).
Ltd. This is an open access article ubeen a National Awareness and Early Diagnosis Initiative
(Department of Health, 2007) to drive service improvement and
research. To better understand the reasons why apparently com-
parable countries differ in their cancer outcomes, an International
Cancer Benchmarking Partnership was established by the Depart-
ment of Health in 2010. Comprising 12 jurisdictions in six countries
on three continents, all with comparablewealth, universal access to
healthcare and high quality cancer registration, it addresses dif-
ferences in epidemiology and population awareness and beliefs
through to primary care behaviours and systems, and includes
exploration of root causes of diagnostic and treatment delay
(Cancer Research UK, 2010; Butler et al., 2013).
Individual, clinical and system factors are related to differences
in cancer survival. Although much is known about patient andnder the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/).
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ature is lacking on health system factors that could help explain
variation in outcomes. Given comparable clinical competencies, the
interaction between different healthcare systems and practitioners
may result in different outcomes. For patients with symptoms that
could indicate cancer, this may impact on the way that they access
healthcare in the first instance and their progress thereafter to the
point of diagnosis (which in turn is related to survival andmortality
(Torring, 2011; Vedsted and Olesen, 2011). The aim of the study
reported here was to compare the characteristics of healthcare
systems in ICBP jurisdictions, as they relate to cancer diagnosis, to
identify characteristics that would plausibly modify the diagnostic
pathway, and thereby outcomes, for patients with suspected
cancer.2. Background
Achieving good cancer outcomes is an important goal for
healthcare systems. Despite increasing scientific, clinical and bio-
logical knowledge on prevention and treatment, cancer remains
one of the leading causes of death and its incidence is increasing in
many countries partly as a result of demographic changes and
increased survival from, for example, cardiovascular diseases
(Coleman et al., 2011; Jemal et al., 2011; Bray et al., 2012; Murray
et al., 2013).
A considerable body of literature exists, demonstrating differ-
ences in survival between countries, even those with apparently
similar healthcare systems (Coleman et al., 2008). In particular,
findings from the EUROCARE studies suggest that Denmark and the
United Kingdom have poorer 1- and 5-year survival rates across a
range of cancer types than other Western European countries (Sant
et al., 2001; Karim-Kos et al., 2008; Berrino et al., 2009; Verdecchia
et al., 2009; Coleman, 2011).
In this paper our baseline comparator is the 1-year survival rate.
Among many elements related to cancer survival (quality of care,
patient behaviour, treatment availability) data suggest that delay in
cancer diagnosis is an important factor related to poor 1-year sur-
vival rates (Gatta et al., 2000; Molassiotis, 2007; Olesen et al., 2009;
Thomson and Forman, 2009; Holmberg et al., 2010; Coleman et al.,
2011; Foot and Harrison, 2011). In many countries initiatives exist
to address this aspect of cancer care (Rubin et al., 2011). However, it
is important to get a more detailed understanding of what is
contributing to diagnostic time intervals. A longer primary care
interval can be a result of, for instance, differences in clinical skills,
access to investigations or the culture and the system in which the
primary care practitioner operates. Simply putting the re-
sponsibility on the practitioner will not provide the explanation,
nor give an indication of how best to intervene to improve
healthcare outcomes.
Explanatory models of the diagnostic process for cancer have
been developed (Olesen et al., 2009; Walter et al., 2012). The pre-
diagnosis period is now generally accepted to have two key phases:
an appraisal/help-seeking interval, influenced by patient behav-
iour, and a diagnostic interval. The latter is subdivided into primary
care, referral and secondary care intervals and during these patient,
practitioner (provider) and system factors may cause delay. Patient
delay in their appraisal of symptoms is generally accepted to play a
significant role (Andersen and Cacioppo, 1995; Macdonald et al.,
2004, 2006; Mitchell et al., 2008) and is influenced by behavioural,
psychological and socio-demographic factors as well as symptom
awareness (Bener et al., 2002; Tromp et al., 2004; Simon et al.,
2010). The interaction between the healthcare system and the
public may also play an important role in patient delay. Patients
may postpone contacting their GP if they have previouslyexperienced barriers to engaging with the healthcare system
(Simon et al., 2010; Andersen et al., 2011).
Although a comparatively short component of overall delay to
diagnosis, primary care delay has received much attention from
researchers. For example, there is a variation by age, gender and
cancer site in the number of GP consultations prior to referral and
the length of time that elapses before referral (Lyratzopoulos et al.,
2013). One of the most significant factors associated with diag-
nostic delay is symptom misattribution or initial misdiagnosis
(Mitchell et al., 2008). Other factors include knowledge, clinical
skills, beliefs, access to relevant investigations, constraining referral
guidelines, or pressure to reduce referrals from general practice.
System factors operate primarily during the interval between
initial referral and final diagnosis, though they can also affect in-
vestigations in primary care. Examples include waiting times for
secondary care, administrative delays, lack of integration between
different levels of care, and inadequate access. Several studies show
that waiting times for tests and lack of referral guidelines are
among the most important issues related to system delay (Bjerager
et al., 2006; Davies et al., 2007). Recently increasing attention has
been paid to finding system solutions to support earlier diagnosis,
including revision and implementation of better referral guidance,
improved access to diagnostic tests, cancer screening improvement
and fast-track pathways for patients with potential cancer
(Molassiotis, 2007; Neal, 2009; Olesen et al., 2009).
Finally, the literature is inconsistent regarding the relationship
between cancer outcomes and health expenditure: some studies
show that higher healthcare spending is not always associated with
better cancer outcome (Kanavos and Schurer, 2010; Sullivan et al.,
2011; Aberg et al., 2012). Others suggest that availability of effec-
tive diagnosis and treatment modalities depends on macro-
economic factors like health investment (Micheli et al., 2003).
The question is whether systems allocating significant resources to
cancer care also perform better: while many other factors have an
impact on cancer outcomes, beyond the level of investment dedi-
cated to cancer or even to the healthcare system as a whole, the
investments made may not automatically lead to better results.
Many factors may explain differences in cancer survival rates,
including patient behaviour, treatment availability, quality of care,
integration of care, stage at diagnosis and treatment and biological
factors (Gatta et al., 2000; Sant et al., 2003). These factors should all
be seen in the context of healthcare as a complex system whose
elements interact in a non-linear way, producing often unexpected
results (Plsek and Greenhalgh, 2001; Lipsitz, 2012). For this reason
a complex system's properties and characteristics should be taken
into account when analyzing or investigating health system issues.
3. Methods
We aimed to compare and describe healthcare systems of three
countries (Denmark, Norway, Sweden), three UK jurisdictions
(England, Wales and Northern Ireland), three Canadian provinces
(British Columbia, Manitoba, Ontario) and two Australian states
(New South Wales, Victoria) using a conceptual framework based
on the work of Starfield and colleagues (Macinko et al., 2003;
Starfield et al., 2005). The framework assesses the contribution of
primary care systems to a range of health outcomes. It draws on the
key characteristics identified and codified by the authors as factors
influencing population health, from macro level characteristics
including national regulation and financing of healthcare to micro
level factors such as access to primary and secondary care and di-
agnostics. These characteristics were shown by Starfield et al. to be
individually associated with good quality primary care. We added a
further factor relevant to cancer diagnosis, namely access to sec-
ondary care, both for patients, and for primary care physicians
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speed of access to the category of access to primary care.
Ethical approval was not required as no human subjects were
involved in the investigation.
The initial investigation comprised a literature review (carried
out in 2013), accessing both peer reviewed and grey literature,
which enabled us to build a detailed picture of overarching in-
fluences such as how healthcare systems were regulated and
financed in each jurisdiction. We took a narrative approach (Mays
et al., 2005) which enabled us to synthesise the different types of
literature and draw out themes across the data to illuminate our
main aim, i.e. to compare different healthcare systems in order to
explore possible factors influencing cancer outcomes.
ICBP Board members for each jurisdiction identified key in-
formants within their countries, to whom an initial draft of the
review was circulated. These were experts in primary care from
both academic and policy backgrounds who provided further de-
tails and corrected any anomalies or errors in the review. This in-
formation was incorporated into a second iteration which again
was circulated to key informants. Through this process, based on
consensus development guidelines (Murphy et al., 1998), we were
able to build a detailed picture based firstly on published literature,
then augmented by the in-depth, key informant local knowledge.
Key features of the healthcare systems we investigated were
grouped under the following headings which are based onMacinko
et al. (2003), which in turn were derived from secondary datasets,
published literature and technical documents, and consultation
with international experts:
 Regulation;
 Financing;
 Primary care provider;
 Centralisation;
 Access to primary care;
 Access to secondary care;
 Longitudinality;
 First contact;
 Comprehensiveness;
 Co-ordination.
We discuss our findings below under each of these headings.
4. Findings
4.1. Regulation
Regulation for the purpose of this study relates to whether na-
tional policies exist that regulate the distribution of primary care
providers and facilities, andwhether health services are available to
all.
All six countries aim at universal population coverage, and for
the most part, exhibit strong centralisation, certainly in terms of
policy-making. In Canada some general standards are set by the
Federal Government, mainly through the Canada Health Act (1984),
but also by virtue of its taxation and spending power. The provincial
governments determine all aspects of healthcare including bud-
gets, resources, and physician and other healthcare worker distri-
bution. Australia also has a federal system, but policies are agreed at
national level and the States and Territories have responsibility for
delivery.
Inequality in the geographical distribution of GPs has long been
a policy concern in the UK, and is a major issue in Canada and
Australia, since areas with the fewest GPs tend to haveworse health
outcomes and greater deprivation. The geographical areas with the
greatest problems with GP recruitment and retention tend to bedeprived urban areas (Sibbald, 2005) in the UK, but rural areas in
Canada and Australia.
The Nordic countries share a common model of healthcare
based on funding through central taxation, universal access, pub-
licly owned hospitals and comprehensive cover. These high level
features suggest similar healthcare systems, but in fact there is
significant variation in the way that healthcare is delivered
(Magnussen et al., 2009). Decision-making is decentralised to
regional boards although in recent years there have been moves
towards “recentralisation” in Denmark. The municipalities, a local
level of administration below the regional boards, have re-
sponsibility for a wide range of health and welfare services
including public health and preventive services. Sweden has the
least centralised decision-making and policy setting of the juris-
dictions reviewed, operating a devolved internal market system.
4.2. Financing
All the European countries included in this review have pri-
marily tax-based systems, considered the most progressive and
cost-effective in terms of their administrative simplicity.
Denmark has separate national health taxes, with healthcare
budgets set annually through negotiation between central gov-
ernment and the regional boards; the state and municipalities set
and collect taxes, with the regions, responsible for the healthcare
system, paid by the state to do this. In Sweden, about 75% of health
funding is raised by local council taxes; the rest comes from central
government. In Norway, tax rates are centrally regulated, though
raised locally with overall funding being a combination of locally
raised taxes and central grant funding.
A key difference between the UK and Nordic jurisdictions is that,
unlike the UK, the Nordic countries' health boards are locally
elected and can make some of their own decisions about raising
finance for healthcare. Decisions on public health spending in En-
gland have recently shifted to local authorities.
Australia and Canada both have insurance schemes that are paid
for mainly from general taxation. In Australia there is also a small
compulsory tax-based health insurance levy (Medicare) that covers
the costs of primary and secondary care through a schedule of fees,
supplemented with patient co-payment. Additionally, approxi-
mately one third of the population carry additional private health
insurance; the Australian Government provides a significant tax
rebate to off-set the cost of private health insurance. Canada's
health insurance programme is also known as “Medicare”. Rather
than a single national plan, it is a national programme comprising
13 provincial and territorial health insurance plans which share
certain common features and basic standards of coverage. Roles
and responsibilities for Canada's healthcare system are shared be-
tween the federal and provincial-territorial governments.
Co-payments for primary care are generally considered a barrier
to access (Gulliford et al., 2002). In England, Wales, Northern
Ireland and Canada there is no cost-sharing for primary medical
care visits. This is also true in Denmark, although about 1% of the
population opt for cost-sharing in return for more freedom of
choice. In Australia some people take out insurance to cover the low
level of cost-sharing, even though for the majority of GP consul-
tations there is no co-payment. In Norway there is a low level of
cost-sharing. In Sweden, there are user charges but these vary be-
tween county councils so there is no national parity. Co-payment
for drugs and prescriptions exist in all countries except Wales.
High secondary care co-payments are also considered a barrier
to access (Gulliford et al., 2002). In most of the countries in this
study, there is no cost-sharing for hospital care through GP referral,
or in Australia where the patient is admitted as a Medicare patient.
In Sweden and Norway there is limited cost-sharing for some
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investigations, the majority of practitioners charge co-payments.
We also considered financial incentives for GPs. England, Wales
and Northern Ireland have operated a quality incentive scheme, the
Quality and Outcomes Framework (QOF), since 2004. QOF provides
financial rewards for achieving specified standards in a large
number of clinical, organizational and patient experience in-
dicators. The impact of QOF has been widely researched and recent
publications show a modest impact on quality improvement and
inequalities reduction (Alshamsan et al., 2010; Checkland and
Harrison, 2010; Gillam et al., 2012). Only two indicators relate to
cancer: maintaining a register of those diagnosed as having cancer,
and undertaking a reviewwithin 6 months of receiving a diagnosis.
Although implementing “Pay for Performance” (P4P) has been
discussed in Canada (Coutts and Thornhill, 2009; Yan et al., 2009)
only Ontario has implemented a widespread scheme to date; this
includes screening for colorectal and cervical cancers. Other prov-
inces are experimenting with limited incentives for chronic disease
management or pilot projects with limited numbers of providers,
none of which relate to cancer. In Australia, the Practice Incentives
Programme (PIP) is made up of a number of incentives including
one on cervical screening.
Sweden's county councils differ in their payment systems to
primary care but most include incentives. Since 2006, they have
been ranked by measures of efficiency and quality. These are not
linked to financial rewards, but the data can support pay-for-
performance schemes at the local level. In Denmark, there are no
reward schemes explicitly tied to performance, although regions
may take action in a case of poor performance.
4.3. Primary care provider
Primary care can be defined as healthcare provided at the first
point of contact with health services (Starfield et al., 2005). Gen-
eralists (general practitioners, family doctors) provide most pri-
mary care in the six countries in the study, along with nurse
practitioners and other primary care nurses. In most of these
countries, the GP also acts as a “gatekeeper” to diagnostic tests and
secondary care, which effectively ensures that almost all patients
have a regular primary care doctor or GP group (Willcox et al.,
2011).
There are significant differences between the jurisdictions
related to GP contracts. GPs in Australia are mostly private practi-
tioners paid for via fee-for-service from public funds and patient
co-payments. In Denmark and Norway GPs are self-employed
(though some Norwegian GPs have public employee status). In
Sweden, approximately 60% of GPs are public employees, 35e40%
employed by private companies and 5e10% self-employed.
In the 3 UK jurisdictions, most GPs are self-employed and con-
tracted to provide general medical services through the NHS. There
are some corporatised practices and some GPs are directly
employed in settings such as out-of-hours/walk-in centres or to
specific sectors of the community, e.g. refugees.
4.4. Centralisation
Central determination of health services in theory is considered
to create consistency of care provision between localities although
empirical evidence may show marked geographical variations
within a single country. Clinical guidelines are also seen as key in
ensuring a nationally consistent standard of care. All the countries
considered here exhibit a strong degree of central determination
but in Sweden, Denmark, Canada and Australia guidance is pro-
duced centrally but decision-making and responsibility for provi-
sion is devolved to local level.All jurisdictions have a current national plan or strategy for
cancer. The extent to which clinical guidelines for cancer are
available and implemented is less consistent. In England, National
Institute for Health and Care Excellence (NICE) guidelines are
available for 27 cancers, and NICE pathways exist for breast, colo-
rectal, lung and ovarian cancers. In Denmark, Cancer Plan II (2005)
implemented guidelines to introduce fast track diagnosis and
treatment pathways for 11 specific cancers. Cancer Plan III (2010)
introduced a national screening programme for colorectal cancer
and a “fast track diagnosis pathway” for patients with nonspecific
symptoms of severe illness that might be cancer, supplementing
the fast track pathways.
Sweden and Norway have national guidelines for most cancer
sites, but in Sweden the emphasis is on secondary care. In Australia,
New South Wales has the first state-wide Cancer Institute in the
country .There are national guidelines now for most cancers in
Australia.
4.5. Access to primary care
Under this heading we consider:
 nurse provision of first contact care;
 alternative locations for primary care provision;
 free patient movement between primary care providers within
an episode of care;
 speed of access.
Table 1 shows locations from which primary care is provided,
and whether patients can move between providers.
Speed of access to primary care is seen as important for earlier
cancer diagnosis, with healthcare providers playing an important
role in facilitating or impeding treatment delay (Walter et al., 2012).
Therefore, proposals to improve clinical outcomes should include
actions directed at patient and primary care delays (Neal, 2009;
Allgar and Neal, 2005). Swedish law requires that patients have
to get a contact the same day they request it, and an appointment
within seven days. Sometimes first contact care is handled by a
nurse. In the 3 UK jurisdictions, national performance targets have
been used to drive improvements in access to general practice.
Until the abolition of these targets (for England, but not Wales or
Northern Ireland) by the coalition government in 2010, patients
were guaranteed access to a primary care professional within
24 hours and to a primary care doctor within 48 hours.
4.6. Access to secondary care
Gatekeeping can serve to control the use of specialist and other
expensive services, thereby restricting healthcare costs. In this
sense it can also be seen as restricting access to otherwise beneficial
healthcare to conserve resources at the expense of the patient. We
considered whether patients can access secondary care directly,
and in most cases, they cannot (see Table 1).
An alternative to specialist referral is for the PCP to directly
access specialist investigations to assess the patient with suspected
cancer.We identified investigations that require specialist input but
which may be made available in this way e upper and lower
gastrointestinal endoscopy, CT/MRI and non-obstetric ultrasound.
We did not include chest radiography or simple blood tests (both
universally available in the ICBP countries). In Table 2 variation in
availability of these investigations is described.
In countries where payment is not required to access secondary
healthcare waiting time can be a barrier to access. The UK and
Denmark have initiated specific processes to reduce waiting times
and enable fast referral especially for diagnostics. GPs refer patients
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varies by country. In the UK jurisdictions, most patients are referred
to a hospital outpatient department, rather than a named specialist.
In Denmark, GPs refer to specialists. In Sweden, referrals can be
direct to an Oncological Centre. In Australia, referrals are generally
to an individual specialist, directly to diagnostic services. A signif-
icant percentage of cancers are still diagnosed after presentation to
the emergency department. In Sweden, patients can bypass the GP
and go direct to hospital or private specialists.
4.7. Longitudinality
Patient lists are considered the optimal way to track patients
over time, and patient registration is associated with better conti-
nuity of care, not least because clinical records are more likely to be
continuous and comprehensive. Most countries have registration
systems, with the exception of Australia. In Sweden, GPs keep pa-
tients' medical records, but not all patients are registered with a
family doctor.
4.8. First contact
First contact refers to the gatekeeping role of GPs, and whether
patients are routinely registered with a GP. In Canada 85% of the
population is registered with a GP, the rate-limiting problem being
availability of GPs. In Denmark it is 99% of the population, and in
other jurisdictions it is close to 100% (99% in Norway and the UK).
Australia does not have a registration system.
4.9. Comprehensiveness
In the four European countries, primary care provides a mix of
services including treatment, minor operations, cervical smears,
family planning, and psychosocial care, although in Sweden there is
a lower level of provision of family planning in primary care than in
the other three countries. Health education/promotion is also car-
ried out at primary care level.
A broader range of services tends to be carried out in primary
care in Canada and Australia than in the European countries we
studied. Most Family Practitioners (FPs) in Canada carry out a full
range of primary care services, and FPs in rural Canada provide a
wider range of services than those in urban areas because of the
comparative lack of access to specialist care. In Australia, mental
healthcare and family planning are both by community services, as
well by GPs. GPs provide general medical care, minor operations,
preventive care such as immunisations, and, as with the other
countries, make referrals for radiology, pathology, and other in-
vestigations. As in Canada, the more rural Australian GPs tend to
offer a broader range of services than urban GPs, in some cases
carrying out more complex surgical procedures such as
appendectomies.
4.10. Co-ordination
Co-ordination relates to the existence of guidelines for the
transfer of information between primary care and other levels, as it
is considered that data transfer is essential for coordinating care
between levels. The existence of electronic records is much more
widespread in Europe than in Canada and Australia. In Denmark, all
GPs use electronic records and can communicate electronically
with hospitals and specialists; referral and discharge letters and lab
results are transferred electronically. In England and Wales, elec-
tronic records are extensively used by GPs. Systems for transfer of
radiology and laboratory results are widespread but there is no
single common system.5. Discussion
A reasonable degree of similarity might be expected between
the healthcare systems of the jurisdictions included in this analysis
given the criteria of the ICBP. This comparison, however, has
revealed some subtle, though possibly significant, differences. We
consider the findings from four perspectives.
5.1. The macro-level view of healthcare systems
All six countries seek to provide universal coverage, most with a
strong degree of centralised policy direction but varying degrees of
devolved decision-making in respect of service delivery. The
number of GPs per 1000 population is remarkably comparable
between European countries but varies widely in Canada and
Australia between urban and rural settings. These differentials
could be expected to exacerbate inequalities in care and in access to
care. Several countries have sought to actively manage the provi-
sion of primary care, in an effort to achieve more equitable distri-
bution of primary healthcare providers.
There are notable differences in the prominence of primary care
within healthcare systems. Those in Norway and Sweden exemplify
systems in which secondary care has dominated. Many of the ju-
risdictions have recent initiatives intended to achieve greater ver-
tical integration of care, an example being Medicare Locals in
Australia, though the current emphasis on integration in England
and Northern Ireland is on horizontal integration between primary
care and social care.
Universal coverage, with tax-based funding, is a feature of all
jurisdictions. In some, notably in Scandinavia, taxes are raised
through a combination of national and local levies. Furthermore, in
some jurisdictions there is a transactional element to healthcare at
the level of the individual patient or GP. This may have the effect of
making the costs of healthcare more evident to patients and doc-
tors, influencing their expectations of the service.
In respect of cancer policy, all jurisdictions have developed a
cancer plan or strategy, and in all cases these are supported by
guidance for clinicians, though they vary widely by stage of
development, comprehensiveness and the time they have been in
place.
5.2. The GP's relationship with the healthcare system
Herewe consider the way inwhich the services provided by GPs
are directed by, or reflect, the policies of their respective healthcare
systems. In all countries other than Sweden, GPs are on the whole
self-employed and contract to provide primary healthcare services.
The nature and quality of the services provided is therefore
managed through a contracting process. In Sweden, where GPs
have been public employees, the recent introduction of private
providers of primary care can be seen as becoming more aligned
with primary care elsewhere, while the element of competition to
provide services distinguishes that country and Australia from the
other jurisdictions.
One means by which quality of care can be managed is through
payment for performance which has been introduced in almost all
jurisdictions. Incentive schemes are widely seen as a means of
improving quality, but they do this selectively only for the aspects
of clinical practice for which incentives exist. For cancer care, in-
centives are limited to engagement with screening programmes,
though some organisational and patient experience criteria may
indirectly impact on cancer care.
GPs are key to demand management within many healthcare
systems. This gatekeeper role is seen as a means to optimise the
efficiency of use of specialised services. However, there is ecological
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for cancer. Among the ICBP jurisdictions, specific referral pathways
for suspected cancer are a feature in Denmark, England, Wales,
Northern Ireland and New South Wales. In Ontario and British
Columbia Diagnostic Assessment Programmes (DAP) are being
established. England is unique in recently reinforcing the gate-
keeping process through the introduction of triage and referral
management systems. These apply external scrutiny, often by other
GPs, to the appropriateness of a referral request. Conversely, some
jurisdictions are freeing up access to specialists, with direct access
in Sweden, rapid access clinics in Denmark and the possibility of
self-referral to a DAP in Ontario, while in New South Wales referral
is largely an on-demand process.5.3. The patient's relationship with the healthcare system
There are significant differences in the nature of the patient's
relationship with their primary care provider. In the UK, Denmark
and Norway there are strong list systems with all citizens required
to be registered with a GP. These are underpinned by comprehen-
sive medical records for each individual being held by their regis-
tered GP. Sweden and Canada have embraced the principles of
patient registration but it is not a comparably comprehensive
process, while in Australia no registration system exists.
Primary care may also be provided in other settings, usually as
an acute service. In particular use of the emergency department is
notable in Manitoba and NSW, while walk-in clinics, typically
intended for minor illness, are a feature of healthcare in England,
Australia and Ontario. There are several considerations with these
alternative providers. First, they do not have access to the
comprehensive medical record; second, for emergency de-
partments theymay expedite specialist assessment; third, for walk-
in clinics they may delay referral, since most patients needing
further assessment are referred back to their GP.
A level of co-payment for primary care services, either directly
or through additional insurance, is a feature of all jurisdictions
other than Canada and the UK. For secondary care it only features in
Australia, Sweden and Norway. Co-payment may bring with it a
stronger sense in the patient of being a ‘consumer’ with attendant
rights and expectations of the healthcare system. Alternatively, for
some patients, the need to pay may deter or even prevent them
from being able to seek help when they first need it.
The strong bond between patient and primary healthcare pro-
vider resulting from registration has recognised benefits, in conti-
nuity of care and access to care. In the absence of comprehensive
patient-held records, it enables the creation and maintenance of a
comprehensive health record. Its weakness may be in suppressing
the ability of patients to switch between providers, thus reducing
competition between providers, which might otherwise drive up
quality of care.5.4. The Patient's relationship with the GP
The services provided by GPs in the ICBP jurisdictions are
broadly comparable. First contact care may be provided by a nurse,
reflecting the multidisciplinary nature of primary care teams. Evi-
dence on the practical experience of appointment systems will
come from the GP survey but we found few data on the ease with
which patients could speak to or see a GP, other than for the UK.
Patients in Australia and, to a lesser extent, Sweden and Canada
are relatively free to move between healthcare providers. This
mobility seems to be associated with an absence of less rigid
registration systems and with more market-driven financial
models. Whilst it is possible for patients in the UK and Danishjurisdictions to move, practical and geographical restrictions make
this less common.
Systems of reimbursement (as in Australia) or co-payment may
introduce expectations on the part of the patient and perceived
obligations on the part of the GP. The latter may mean that patient
demand over-rides clinical judgement. In countries where the
transactional relationship is not as explicit, the scope is greater for
clinical judgement to dominate. In most circumstances need should
prevail over demand, but for conditions such as cancer where
clinical assessment is necessarily imprecise, patients may not have
specialist assessment as quickly as might otherwise occur.6. Strengths and limitations
Differences in 1- and 5-year survival rates for cancer despite
comparable wealth and universal access to healthcare underpinned
participation in the ICBP and therefore inclusion in this compara-
tive study. These are both imperfect measures of speed and time-
liness of diagnosis, though the best that is widely available. Five
year survival is also affected by differences in treatment, while one
year survival is modified by time taken by patients to seek
healthcare. Furthermore, the analyses that demonstrated these
differences were based on data to 1999 (Abdel Rahman et al., 2009)
and do not reflect more recent changes in healthcare provision.
However, a recent analysis of data to 2007 has confirmed that these
differences in outcome largely persist (De Angelis et al., 2013).
Key informants were selected by the ICBP Board member for
their jurisdiction. The principal requirement was an expert over-
view of the organisation and delivery of healthcare in their country,
with particular reference to primary care and cancer care. They
were used largely to validate information gathered by the research
team, but also added detail where it was missing. There was no
formal measure of this expertise, however, and it is possible that by
using a maximum of three in any single jurisdiction, we failed to
gather relevant information that a wider group of informants could
have provided.7. Conclusions
This paper is a first attempt to investigate if, and at what level,
health system factors could contribute to differences in cancer
outcomes. Our findings show that for many of the characteristics
we investigated there are no systematic and significant differences
between those countries with poorer cancer outcomes (England
and Denmark) and the rest. In particular, regulation, financing, the
gatekeeping role of GPs, direct access to secondary care, the degree
of comprehensiveness of primary care services provided, the level
of cost sharing, and the type of primary care providers within
healthcare systems are not particularly aligned with the differences
in cancer outcome. There are, however, some factors that could
have an influence on patient and professional behaviour and
consequently contribute to differences in cancer outcomes.
 Centralisation
Despite all the jurisdictions having a degree of central deter-
mination of cancer policies, in some, decision-making is devolved
to the local level. The debate about the effects on patient outcomes
of either centralising or decentralising the key levers in health
systems has thus far proved inconclusive (Saltman et al., 2007). It is
therefore uncertain whether the degree of centralisation has a
significant influence on cancer outcomes, although this factor e
particularly in regard to local interpretation and implementation of
cancer guidelines e merits further research.
S. Brown et al. / Social Science & Medicine 116 (2014) 56e6362 Free movement of patients between primary care providers
This issue also presents some differences between countries:
opportunities for patients to move more freely between different
providers could help to improve early cancer diagnosis by
providing a competitive incentive for the PCP to ensure optimal
care or by enabling patients to seek second opinions.
 Access to secondary care
Most jurisdictions do not have secondary care co-payments. In
some their absence could create waiting lists that could have a
detrimental impact on early cancer diagnosis. Alternatively, co-
payments could deter patients from seeking help at an earlier
stage, when treatments could be provided that are simpler, and
possibly at less cost.
 List system
There are differences between countries in the comprehen-
siveness of coverage and the provision of a ‘medical home’ that
comes with registration.
These issues need deeper analysis because at this stage of the
research it is not possible to establish a direct causal inference
between health system issues and cancer outcomes. Further studies
should aim at deepening this analysis by exploring associations
between healthcare system characteristics and cancer outcomes
(Cohn et al., 2013). In particular, the complex relationship between
co-payment and patient behaviour needs further exploration. It
seems likely that in jurisdictions with co-payments, patient
behaviour will differ depending on whether or not the patient can
afford the payment or regards it as a barrier to seeking treatment.
Better understanding of the interaction between health system
variables and patient and professional behaviour may result in
improved outcomes.
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